Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson s disease

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Luan, Hemi ^a   Liu, Liang Feng ^a   Tang, Zhi ^a   Zhang, Manwen ^a   Chua, Ka Kit ^a   Song, Ju Xian ^a   Mok, Vincent C T ^b   Li, Min ^a   Cai, Zongwei ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BIOLOGICAL MARKER;

ADULT; AGED; CASE CONTROL STUDY; DISCRIMINANT ANALYSIS; DISEASE COURSE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LEAST SQUARE ANALYSIS; MALE; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLOME; METABOLOMICS; MIDDLE AGED; PARKINSON DISEASE; PATHOLOGY; PHENOTYPE; SEVERITY OF ILLNESS INDEX; URINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACIDS; BIOMARKERS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISCRIMINANT ANALYSIS; DISEASE PROGRESSION; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LEAST-SQUARES ANALYSIS; MALE; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; MIDDLE AGED; PARKINSON DISEASE; PHENOTYPE; SEVERITY OF ILLNESS INDEX;

EID: 84941585534     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13888     Document Type: Article

References (42)

1. de Lau, L. M. & Breteler, M. M. Epidemiology of Parkinsons disease. Lancet Neurol 5, 525-535 (2006).
2. Alexander, G. E. Biology of Parkinsons disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder. Dialogues Clin Neurosci 6, 259-280 (2004).
3. Jankovic, J. Parkinsons disease: clinical features and diagnosis. Journal of Neurology, Neurosurgery & Psychiatry 79, 368-376 (2008).
4. Chen, H., Zhang, S. M., Hernan, M. A., Willett, W. C. & Ascherio, A. Weight loss in Parkinsons disease. Ann Neurol 53, 676-679 (2003).
5. Lorefalt, B., Toss, G. & Granerus, A. K. Weight loss, body fat mass, and leptin in Parkinsons disease. Mov Disord 24, 885-890 (2009).
6. Palacios, N., Gao, X., Schwarzschild, M. & Ascherio, A. Declining quality of life in Parkinson disease before and after diagnosis. J Parkinsons Dis 2, 153-160 (2012).
7. Phillipson, O. T. Management of the aging risk factor for Parkinsons disease. Neurobiol Aging 35, 847-857 (2014).
8. Goldman, S. M. Environmental toxins and Parkinsons disease. Annu Rev Pharmacol Toxicol 54, 141-164 (2014).
9. Abidi, P. et al. Oxidative stress-induced inhibition of adrenal steroidogenesis requires participation of p38 mitogen-activated protein kinase signaling pathway. J Endocrinol 198, 193-207 (2008).
10. Lerch, J. K., Puga, D. A., Bloom, O. & Popovich, P. G. Glucocorticoids and macrophage migration inhibitory factor (MIF) are neuroendocrine modulators of inflammation and neuropathic pain after spinal cord injury. Semin Immunol 26, 409-414 (2014).
11. Maetzler, W. et al. Comparable autoantibody serum levels against amyloid- and inflammation-associated proteins in Parkinsons disease patients and controls. PLoS One 9, e88604 (2014).
12. Berman, A. E. et al. N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1? /? mouse. Annals of neurology 69, 509-520 (2011).
13. Sévin, D. C., Kuehne, A., Zamboni, N. & Sauer, U. Biological insights through nontargeted metabolomics. Current opinion in biotechnology 34, 1-8 (2015).
14. Lewitt, P. A., Li, J., Lu, M., Beach, T. G., Adler, C. H. & Guo, L. 3-hydroxykynurenine and other Parkinsons disease biomarkers discovered by metabolomic analysis. Mov Disord 28, 1653-1660 (2013).
15. Michell, A. W., Mosedale, D., Grainger, D. J. & Barker, R. A. Metabolomic analysis of urine and serum in Parkinsons disease. Metabolomics 4, 191-201 (2008).
16. Bogdanov, M. et al. Metabolomic profiling to develop blood biomarkers for Parkinsons disease. Brain 131, 389-396 (2008).
17. Poliquin, P. O., Chen, J., Cloutier, M., Trudeau, L.-É. & Jolicoeur, M. Metabolomics and In-Silico Analysis Reveal Critical Energy Deregulations in Animal Models of Parkinsons Disease. PLoS One 8, e69146 (2013).
18. Bouatra, S. et al. The human urine metabolome. PLoS One 8, e73076 (2013).
19. Luan, H. et al. LC-MS-Based Urinary Metabolite Signatures in Idiopathic Parkinsons Disease. Journal of proteome research 14, 467-478 (2015).
20. Fernstrom, J. D. Branched-chain amino acids and brain function. The Journal of nutrition 135, 1539S-1546S (2005).
21. Moriwaki, H., Miwa, Y., Tajika, M., Kato, M., Fukushima, H. & Shiraki, M. Branched-chain amino acids as a protein-and energysource in liver cirrhosis. Biochem Bioph Res Co 313, 405-409 (2004).
22. Mally, J., Szalai, G. & Stone, T. Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinsons disease. J Neurol Sci 151, 159-162 (1997).
23. Molina, J. A. et al. Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinsons disease. J Neurol Sci 150, 123-127 (1997).
24. Yadid, G. et al. Glycine stimulates striatal dopamine release in conscious rats. British journal of pharmacology 110, 50-53 (1993).
25. Hernandes, M. S. & de Magalhães, L., Troncone LRP. Glycine stimulates the release of labeled acetylcholine but not dopamine nor glutamate from superfused rat striatal tissue. Brain research 1168, 32-37 (2007).
26. Pettersen, J. E. & Jellum, E. The identification and metabolic origin of 2-furoylglycine and 2, 5-furandicarboxylic acid in human urine. Clinica chimica acta 41, 199-207 (1972).
27. Joergensen, A. et al. Association between urinary excretion of cortisol and markers of oxidatively damaged DNA and RNA in humans. PLoS One 6, e20795 (2011).
28. Moroni, F. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites. European journal of pharmacology 375, 87-100 (1999).
29. Widner, B., Leblhuber, F. & Fuchs, D. Increased neopterin production and tryptophan degradation in advanced Parkinsons disease. Journal of Neural Transmission 109, 181-189 (2002).
30. Ramdani, C., Carbonnell, L., Vidal, F., Béranger, C., Dagher, A. & Hasbroucq, T. Dopamine precursors depletion impairs impulse control in healthy volunteers. Psychopharmacology. 1-11 (2014).
31. Antonio Molina, J. et al. Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinsons disease. J Neurol Sci 150, 123-127 (1997).
32. Engelborghs, S., Marescau, B. & De Deyn, P. P. Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinsons disease. Neurochem Res 28, 1145-1150 (2003).
33. Sandler, M., Karoum, F., Ruthven, C. & Calne, D. m-Hydroxyphenylacetic acid formation from L-dopa in man: suppression by neomycin. Science 166, 1417-1418 (1969).
34. Kobayashi, K., Imazu, Y. & Shohmori, T. p-Hydroxyphenylacetic Acid Concentration in the CSF of Patients with Neurological and Psychiatric Disorders. In: Neurobiology of the Trace Amines (eds Boulton, A. A. et al.) 543-548 (Humana Press, 1984).
35. Williams-Gray, C. H., Foltynie, T., Brayne, C. E., Robbins, T. W. & Barker, R. A. Evolution of cognitive dysfunction in an incident Parkinsons disease cohort. Brain 130, 1787-1798 (2007).
36. Smart, K. F., Aggio, R. B., Van Houtte, J. R. & Villas-Boas, S. G. Analytical platform for metabolome analysis of microbial cells using methyl chloroformate derivatization followed by gas chromatography-mass spectrometry. Nat Protoc 5, 1709-1729 (2010).
37. Cheng, Y. et al. Distinct urinary metabolic profile of human colorectal cancer. Journal of proteome research 11, 1354-1363 (2011).
38. Zelena, E. et al. Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. Anal Chem 81, 1357-1364 (2009).
39. Dunn, W. B. et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 6, 1060-1083 (2011).
40. Wang, X. et al. Urinary metabolite variation is associated with pathological progression of the post-hepatitis B cirrhosis patients. Journal of proteome research 11, 3838-3847 (2012).
41. Veselkov, K. A. et al. Optimized preprocessing of ultra-performance liquid chromatography/mass spectrometry urinary metabolic profiles for improved information recovery. Analytical Chemistry 83, 5864-5872 (2011).
42. Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. Bmc Bioinformatics 12, 77 (2011).